Leukaemia Trial, Recruiting NCT06056908 Sponsor: Boston Children's Hospital Condition: Leukaemia
Back to Leukaemia

Leukaemia Trial, Recruiting

NCT06056908
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with Shwachman-Diamond Syndrome (SDS), a similar condition, or an unidentified condition that shares features with SDS
  • People who have specific genetic changes (mutations) in genes known as SBDS, DNAJC21, EFL1, or SRP54 that are linked to SDS
  • People whose SDS diagnosis was made based on physical signs and symptoms, even without genetic confirmation
  • People who are suspected of having SDS based on their symptoms or test results
  • People who show physical characteristics that suggest they may have SDS
  • Blood relatives (such as parents, brothers, sisters, or other family members) of any age — including those who have passed away — of people with SDS or a similar condition

Who may not be able to join:

  • People who have been diagnosed with another known condition that causes bone marrow failure, problems with the pancreas not absorbing food properly, or a higher risk of developing cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Boston Children's Hospital
Registry
ClinicalTrials.gov
Start date
19 January 2016
Est. completion
1 January 2090

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Characterize the natural history, medical complications, and treatment outcomes for patients with SDS and SDS-Like conditions.; Investigate the molecular and genetic pathogenesis of SDS/SDS-Like condtions and their complications such as marrow failure and clonal evolution.; Identify new genes causing SDS/SDS-Like conditions; Provide education on the diagnosis, medical management, and treatment of SDS/SDS-Like conditions for patients, families, and the medical/scientific community.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov